Lyell Immunopharma, Inc. Business Finance Contracts & Agreements

13 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Registration Rights Agreement among Lyell Immunopharma, Inc., Sellers, and WT Representative LLC (October 31, 2024)
Registration Rights Agreements
Lyell Immunopharma, Inc.
Biotechnology
DE
2024
Lyell Immunopharma, Inc. Amendment to Stock Options for Elizabeth Homans (Extension of Exercise Period)
Modification Agreements
Lyell Immunopharma, Inc.
Biotechnology
2022
Lyell Immunopharma, Inc. 2021 Employee Stock Purchase Plan
Equity Distribution Agreements
Lyell Immunopharma, Inc.
Biotechnology
2021
Lyell Immunopharma, Inc. Global RSU Award Agreement (2021 Equity Incentive Plan)
Equity Distribution Agreements
Lyell Immunopharma, Inc.
Biotechnology
DE
2021
Lyell Immunopharma, Inc. Global Stock Option Grant Notice and Agreement (2021 Equity Incentive Plan)
Stock Agreements
Lyell Immunopharma, Inc.
Biotechnology
DE
2021
Lyell Immunopharma, Inc. 2021 Equity Incentive Plan
Equity Distribution Agreements
Lyell Immunopharma, Inc.
Biotechnology
DE
2021
Common Stock Certificate of Lyell Immunopharma, Inc.
Stock Agreements
Lyell Immunopharma, Inc.
Biotechnology
2021
Lyell Immunopharma, Inc. Common Stock Underwriting Agreement with Goldman Sachs, BofA Securities, J.P. Morgan, and Morgan Stanley
Underwriting Agreements
Lyell Immunopharma, Inc.
Biotechnology
2021
Success Payment Commitment Agreement between Lyell Immunopharma, Inc. and Fred Hutchinson Cancer Research Center
Financing Agreements
Lyell Immunopharma, Inc.
Biotechnology
2021
Success Payment Commitment Agreement between Lyell Immunopharma, Inc. and Stanford University
Financing Agreements
Lyell Immunopharma, Inc.
Biotechnology
2021
Lyell Immunopharma, Inc. 2018 Equity Incentive Plan Stock Option Grant and Agreement
Warrant Agreements
Lyell Immunopharma, Inc.
Biotechnology
CA
2021
Lyell Immunopharma, Inc. 2018 Equity Incentive Plan (as Amended)
Equity Distribution Agreements
Lyell Immunopharma, Inc.
Biotechnology
CA
2021
Amended and Restated Investors' Rights Agreement among Lyell Immunopharma, Inc. and Investors (March 5, 2020)
Investor Rights Agreements
Lyell Immunopharma, Inc.
Biotechnology
DE
2021